| CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers HR Jung, Y Oh, D Na, S Min, J Kang, D Jang, S Shin, J Kim, SE Lee, ... Oncogene 40 (18), 3287-3302, 2021 | 25 | 2021 |
| Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers Y Oh, HR Jung, S Min, J Kang, D Jang, S Shin, J Kim, SE Lee, CO Sung, ... Cancer Letters 497, 123-136, 2021 | 13 | 2021 |
| Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types J Oh, C Hwa, D Jang, S Shin, SJ Lee, J Kim, SE Lee, HR Jung, Y Oh, ... Experimental & Molecular Medicine 54 (7), 906-921, 2022 | 12 | 2022 |
| METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors Y Kim, S Shin, S Kwon, K Moon, SV Baek, A Jo, HS Kim, GH Hwang, ... American journal of cancer research 13 (4), 1443, 2023 | 6 | 2023 |
| Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathway HR Jung, Y Oh, D Jang, S Shin, SJ Lee, J Kim, SE Lee, J Oh, G Jang, ... Genes & Genomics 45 (1), 71-81, 2023 | 2 | 2023 |
| RNA N6‐Methyladenosine‐Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN‐γ Signaling in Gastric Cancer D Jang, C Hwa, S Kim, J Oh, S Shin, SJ Lee, J Kim, SE Lee, Y Yang, ... Advanced Science, 2410806, 2025 | | 2025 |
| Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy Y Oh, S Kim, Y Kim, H Kim, D Jang, S Shin, SJ Lee, J Kim, SE Lee, J Oh, ... Molecular Cancer 23 (1), 155, 2024 | | 2024 |
| RNA N6-Methyladenosine-Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN-𝜸 Signaling in Gastric Cancer D Jang, C Hwa, S Kim, J Oh, S Shin, SJ Lee, J Kim, SE Lee, Y Yang, ... | | 2024 |
